Tummon I S, Daniel S A, Kaplan B R, Nisker J A, Yuzpe A A
Department of Gynaecology and Reproductive Medicine, University of Western Ontario, London, Canada.
Fertil Steril. 1992 Sep;58(3):563-8.
To compare luteal phase leuprolide acetate (LA) initiated pituitary down regulation followed by human menopausal gonadotropins (hMG) versus clomiphene citrate (CC) and hMG for follicular recruitment and oocyte maturation before in vitro fertilization (IVF).
Randomized, prospective comparison in first cycles of IVF.
University Hospital, a tertiary referral center offering assisted reproductive technologies.
Participants were couples undergoing their first ever cycle of IVF and consenting to participation in the trial.
Luteal phase initiated LA/hMG was associated with a lower probability of cycle cancellation, improved folliculogenesis, and a higher probability of embryo transfer (ET) compared with CC/hMG alone. Implantation rates were not different.
A higher rate of ET with LA/hMG suggests that gonadotropin-releasing hormone agonist for the induction of folliculogenesis before IVF may be appropriate.
比较在体外受精(IVF)前,黄体期开始使用醋酸亮丙瑞林(LA)启动垂体降调节,随后使用人绝经期促性腺激素(hMG)与使用枸橼酸氯米芬(CC)和hMG进行卵泡募集及卵母细胞成熟的情况。
IVF首个周期的随机前瞻性比较。
大学医院,一家提供辅助生殖技术的三级转诊中心。
参与者为首次进行IVF周期且同意参与试验的夫妇。
与单独使用CC/hMG相比,黄体期开始使用LA/hMG与周期取消概率较低、卵泡生成改善及胚胎移植(ET)概率较高相关。着床率无差异。
LA/hMG的ET率较高表明,IVF前用于诱导卵泡生成的促性腺激素释放激素激动剂可能是合适的。